Bioequivalence Study of Sorafenib Tablet and Nexavar

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Randomized, open-label, 3-way reference replicated crossover bioequivalence study of sorafenib 200 mg tablet and nexavar (reference) following a 200 mg dose in healthy subjects under fasting conditions.
Epistemonikos ID: 6c663c9b4f5ff333b5410d3722ef2b4c7417ae62
First added on: May 12, 2024